187 related articles for article (PubMed ID: 10090407)
1. Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.
Adsay NV; Dergham ST; Koppitch FC; Dugan MC; Mohamed AN; Vaitkevicius VK; Sarkar FH
Pancreas; 1999 Mar; 18(2):111-6. PubMed ID: 10090407
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma].
Zeng X; Wu SF; Xu Q; Xiao Y; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):523-8. PubMed ID: 17134545
[TBL] [Abstract][Full Text] [Related]
3. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
Qian J; Jenkins RB; Bostwick DG
Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
[TBL] [Abstract][Full Text] [Related]
4. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
5. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
Schleger C; Verbeke C; Hildenbrand R; Zentgraf H; Bleyl U
Mod Pathol; 2002 Apr; 15(4):462-9. PubMed ID: 11950922
[TBL] [Abstract][Full Text] [Related]
6. Investigation of c-myc and p53 gene alterations in the tumor and surgical borderline tissues of NSCLC and effects on clinicopathologic behavior: by the FISH technique.
Yakut T; Egeli U; Gebitekin C
Lung; 2003; 181(5):245-58. PubMed ID: 14705768
[TBL] [Abstract][Full Text] [Related]
7. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma.
Armengol G; Knuutila S; Lluís F; Capellà G; Miró R; Caballín MR
Cancer Genet Cytogenet; 2000 Jan; 116(2):133-41. PubMed ID: 10640145
[TBL] [Abstract][Full Text] [Related]
8. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization.
Sauter G; Carroll P; Moch H; Kallioniemi A; Kerschmann R; Narayan P; Mihatsch MJ; Waldman FM
Am J Pathol; 1995 May; 146(5):1131-9. PubMed ID: 7747807
[TBL] [Abstract][Full Text] [Related]
9. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer.
Mark HF; Samy M; Santoro K; Mark S; Feldman D
Exp Mol Pathol; 2000 Feb; 68(1):65-9. PubMed ID: 10640455
[TBL] [Abstract][Full Text] [Related]
12. Copy number of chromosome 17 but not HER2 amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinoma.
Stoecklein NH; Luebke AM; Erbersdobler A; Knoefel WT; Schraut W; Verde PE; Stern F; Scheunemann P; Peiper M; Eisenberger CF; Izbicki JR; Klein CA; Hosch SB
J Clin Oncol; 2004 Dec; 22(23):4737-45. PubMed ID: 15570074
[TBL] [Abstract][Full Text] [Related]
13. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
14. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
Ozakyol A; Ozdemir M; Artan S
Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
[TBL] [Abstract][Full Text] [Related]
15. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma.
Fukushige S; Waldman FM; Kimura M; Abe T; Furukawa T; Sunamura M; Kobari M; Horii A
Genes Chromosomes Cancer; 1997 Jul; 19(3):161-9. PubMed ID: 9218997
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics.
Visscher DW; Wallis T; Awussah S; Mohamed A; Crissman JD
Genes Chromosomes Cancer; 1997 Jan; 18(1):1-7. PubMed ID: 8993975
[TBL] [Abstract][Full Text] [Related]
17. Analysis of MYC and chromosome 8 copy number changes in gastrointestinal cancers by dual-color fluorescence in situ hybridization.
Takahashi Y; Shintaku K; Ishii Y; Asai S; Ishikawa K; Fujii M
Cancer Genet Cytogenet; 1998 Nov; 107(1):61-4. PubMed ID: 9809036
[TBL] [Abstract][Full Text] [Related]
18. Loss of chromosome 18q is an early event in pancreatic ductal tumorigenesis.
Fukushige S; Furukawa T; Satoh K; Sunamura M; Kobari M; Koizumi M; Horii A
Cancer Res; 1998 Oct; 58(19):4222-6. PubMed ID: 9766641
[TBL] [Abstract][Full Text] [Related]
19. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
[TBL] [Abstract][Full Text] [Related]
20. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]